180 results
DEFA14A
IBRX
ImmunityBio Inc
29 Apr 24
Additional proxy soliciting materials
4:20pm
as ImmunityBio’s independent registered public accounting firm for the fiscal year ending December 31, 2024. For NOTE: In their discretion, the proxies
S-3ASR
IBRX
ImmunityBio Inc
17 Apr 24
Automatic shelf registration
5:24pm
writing prospectus may contain and incorporate by reference, market data and industry statistics and forecasts that are based on independent industry … of independent public accountants or investment bank to pay and discharge each installment of principal, premium and interest on and any mandatory sinking fund
S-3ASR
EX-23.1
IBRX
ImmunityBio Inc
17 Apr 24
Automatic shelf registration
5:24pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts
S-3ASR
EX-4.3
mq8mj yhbok
17 Apr 24
Automatic shelf registration
5:24pm
424B5
t7j8bd4m90ezy3w
24 Jul 23
Prospectus supplement for primary offering
5:12pm
8-K
EX-1.1
vbl d2q2j
21 Jul 23
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
6:04am
8-K
EX-10.1
lwjzzzmwfas86g60v9
21 Jul 23
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
6:04am
8-K
EX-4.1
gwyg8xwc7fmn
21 Jul 23
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
6:04am